Johnson Matthey PLC (LON:JMAT - Get Free Report)'s share price hit a new 52-week low during trading on Wednesday . The company traded as low as GBX 1,388 ($17.45) and last traded at GBX 1,405 ($17.66), with a volume of 595327 shares. The stock had previously closed at GBX 1,493 ($18.77).
Johnson Matthey Price Performance
The company has a debt-to-equity ratio of 63.15, a current ratio of 1.45 and a quick ratio of 0.76. The firm has a 50-day moving average of GBX 1,520.43 and a 200-day moving average of GBX 1,616.82. The stock has a market cap of £2.30 billion, a PE ratio of 2,361.47, a PEG ratio of 49,242.50 and a beta of 0.95.
Johnson Matthey Cuts Dividend
The company also recently disclosed a dividend, which will be paid on Tuesday, February 4th. Investors of record on Thursday, December 5th will be issued a GBX 22 ($0.28) dividend. The ex-dividend date is Thursday, December 5th. This represents a dividend yield of 1.47%. Johnson Matthey's payout ratio is currently 13,275.86%.
Insiders Place Their Bets
In other Johnson Matthey news, insider Stephen Oxley purchased 7,407 shares of Johnson Matthey stock in a transaction that occurred on Wednesday, November 27th. The stock was bought at an average price of GBX 1,343 ($16.88) per share, with a total value of £99,476.01 ($125,048.41). Also, insider Liam Condon bought 27 shares of the company's stock in a transaction dated Wednesday, October 16th. The stock was bought at an average price of GBX 1,505 ($18.92) per share, for a total transaction of £406.35 ($510.81). Insiders purchased a total of 7,479 shares of company stock worth $10,057,890 over the last 90 days. Company insiders own 0.61% of the company's stock.
About Johnson Matthey
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
See Also
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
